Institutional investors hold a majority ownership of AMGN through the 83.52% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended September 2014, these large investors purchased a net $11.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ATALANTA SOSNOFF MANAGEMENT LLC Bought 269.9 Thousand shares of Amgen
STATE STREET GLOBAL ADVISORS LTD... Bought 189.3 Thousand shares of Amgen
NORDEA INVESTMENT MANAGEMENT AB ... Bought 136.9 Thousand shares of Amgen